Literature DB >> 8214011

Localization of dystrophin and beta-spectrin in vacuolar myopathies.

J L De Bleecker1, A G Engel, J C Winkelmann.   

Abstract

We examined the expression of the cytoskeletal proteins dystrophin and beta-spectrin on vacuolar boundaries in vacuolar myopathies. We also localized utrophin, a dystrophin homologue, and laminin, which served as a marker for the basal lamina. Four types of vacuoles were identified. Type 1 vacuoles, found in all diseases, were lined by laminin, dystrophin, and beta-spectrin and arose from infoldings of the basal lamina and sarcolemma into splitting or branching fibers. Type 2 vacuoles were lined by dystrophin and beta-spectrin and were most common in adult acid maltase deficiency, chloroquine myopathy, and periodic paralysis. Traces of utrophin were also noted on the boundaries of some type 2 vacuoles, but only in those fibers that also expressed utrophin on their surface membrane. Type 3 vacuoles were lined by small patches of dystrophin and beta-spectrin and occurred in any vacuolar myopathy. Type 4 vacuoles were unlined by any of the above antigens and were most common in infantile acid maltase deficiency and in the nonlysosomal glycogenoses. Immunoelectron microscopy confirmed the dystrophin label on vacuolar boundaries but revealed no reaction product on any other membranous component within the muscle fiber. We conclude that dystrophin and beta-spectrin provide cytoskeletal support for a species of membrane-bound vacuoles in diverse myopathies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8214011      PMCID: PMC1887052     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Immunocytochemical studies of spectrin in hamster cardiac tissue.

Authors:  D A Messina; L F Lemanski
Journal:  Cell Motil Cytoskeleton       Date:  1989

2.  Immunoelectron microscopic localization of dystrophin in myofibres.

Authors:  S C Watkins; E P Hoffman; H S Slayter; L M Kunkel
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

3.  Evidence for the association of dystrophin with the transverse tubular system in skeletal muscle.

Authors:  C M Knudson; E P Hoffman; S D Kahl; L M Kunkel; K P Campbell
Journal:  J Biol Chem       Date:  1988-06-15       Impact factor: 5.157

4.  Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface.

Authors:  E Bonilla; C E Samitt; A F Miranda; A P Hays; G Salviati; S DiMauro; L M Kunkel; E P Hoffman; L P Rowland
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

5.  Dystrophin is localized to the plasma membrane of human skeletal muscle fibers by electron-microscopic cytochemical study.

Authors:  S Carpenter; G Karpati; E Zubrzycka-Gaarn; D E Bulman; P N Ray; R G Worton
Journal:  Muscle Nerve       Date:  1990-05       Impact factor: 3.217

6.  An autosomal transcript in skeletal muscle with homology to dystrophin.

Authors:  D R Love; D F Hill; G Dickson; N K Spurr; B C Byth; R F Marsden; F S Walsh; Y H Edwards; K E Davies
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

7.  Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy.

Authors:  E P Hoffman; K H Fischbeck; R H Brown; M Johnson; R Medori; J D Loike; J B Harris; R Waterston; M Brooke; L Specht
Journal:  N Engl J Med       Date:  1988-05-26       Impact factor: 91.245

8.  Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide.

Authors:  K Arahata; S Ishiura; T Ishiguro; T Tsukahara; Y Suhara; C Eguchi; T Ishihara; I Nonaka; E Ozawa; H Sugita
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

9.  Association of dystrophin and an integral membrane glycoprotein.

Authors:  K P Campbell; S D Kahl
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

10.  Cell fractionation studies indicate that dystrophin is a protein of surface membranes of skeletal muscle.

Authors:  G Salviati; R Betto; S Ceoldo; E Biasia; E Bonilla; A F Miranda; S Dimauro
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

View more
  9 in total

1.  The spectrin skeleton of newly-invaginated plasma membrane.

Authors:  T L Herring; P Juranka; J Mcnally; H Lesiuk; C E Morris
Journal:  J Muscle Res Cell Motil       Date:  2000-01       Impact factor: 2.698

2.  Accessibility of T-tubule vacuoles to extracellular dextran and DNA: mechanism and potential application of vacuolation.

Authors:  S A Krolenko; W B Amos; S C Brown; M V Tarunina; J A Lucy
Journal:  J Muscle Res Cell Motil       Date:  1998-08       Impact factor: 2.698

3.  Specific interaction of the actin-binding domain of dystrophin with intermediate filaments containing keratin 19.

Authors:  Michele R Stone; Andrea O'Neill; Dawn Catino; Robert J Bloch
Journal:  Mol Biol Cell       Date:  2005-07-06       Impact factor: 4.138

4.  Discrete and reversible vacuole-like dilations induced by osmomechanical perturbation of neurons.

Authors:  C Reuzeau; L R Mills; J A Harris; C E Morris
Journal:  J Membr Biol       Date:  1995-05       Impact factor: 1.843

5.  Autophagic vacuolar pathology in desminopathies.

Authors:  Conrad C Weihl; Stanley Iyadurai; Robert H Baloh; Sara K Pittman; Robert E Schmidt; Glenn Lopate; Alan Pestronk; Matthew B Harms
Journal:  Neuromuscul Disord       Date:  2014-12-12       Impact factor: 4.296

Review 6.  Autophagy and mitochondria in Pompe disease: nothing is so new as what has long been forgotten.

Authors:  Nina Raben; Amanda Wong; Evelyn Ralston; Rachel Myerowitz
Journal:  Am J Med Genet C Semin Med Genet       Date:  2012-01-17       Impact factor: 3.908

7.  Ultrastructural localization of the C-terminus of the 43-kd dystrophin-associated glycoprotein and its relation to dystrophin in normal murine skeletal myofiber.

Authors:  Y Wakayama; S Shibuya; A Takeda; T Jimi; Y Nakamura; H Oniki
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

8.  Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies.

Authors:  J L De Bleecker; A G Engel
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

9.  Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease.

Authors:  Marina Fanin; Anna C Nascimbeni; Luigi Fulizio; Marco Spinazzi; Paola Melacini; Corrado Angelini
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.